Medpace Holdings Rg
MEDP
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
12/27/2024 - 16:30:00
Bid
12/27/2024 - 15:59:59
Bid
Volume
Ask
12/27/2024 - 15:59:59
Ask
Volume
341.12
-1.80 ( -0.52% )
341.07
300
341.71
100
More information
Analysis by TheScreener
24.12.2024
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 24.12.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 13.12.2024.
Interest
  Strong
Strong interest since 17.12.2024.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.12.2024 at a price of 345.93.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 06.12.2024), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 334.541.
4wk Rel Perf
  0.56%
 
The four week relative performance versus SP500 is .
Sensibility
  Middle
Moderate, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.48%.
Mkt Cap in $bn
  10.54
With a market capitalization >$8bn, MEDPACE HOLDINGS is considered a large-cap stock.
G/PE Ratio
  0.67
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  24.42
The estimated PE is for the year 2026.
LT Growth
  16.44%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  7
Over the last seven weeks, an average of 7 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  147
For 1% of index variation, the stock varies on average by 1.47%.
Correlation
  0.42
42.28% of stock movements are explained by index variations.
Value at Risk
  73.12
The value at risk is estimated at USD 73.12. The risk is therefore 21.34%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  27.11.2020